3,179
Views
4
CrossRef citations to date
0
Altmetric
Public Health & Policy

A review of factors influencing vaccination policies and programs for older adults globally

ORCID Icon, &
Article: 2157164 | Received 27 Sep 2022, Accepted 07 Dec 2022, Published online: 19 Jan 2023

References

  • World Health Organization (WHO). Immunization Agenda 2030: a global strategy to leave no one behind; 2022 [accessed 2022 Nov 18]. https://www.who.int/teams/immunization-vaccines-and-biologicals/strategies/ia2030#:~:text=The%20World%20Health%20Assembly%2C%20with,save%20over%2050%20million%20lives.
  • Bloom D, Fan V, Sevilla J. The broad socioeconomic benefits of vaccination. Sci Transl Med. 2018;10(441):eaaj234. doi:10.1126/scitranslmed.aaj2345.
  • Dorrington M, Bowdish D. Immunosenescence and novel vaccination strategies for the elderly. Front Immunol. 2013;4:171. doi:10.3389/fimmu.2013.00171.
  • United Nations Department of Economic and Social Affairs, Population Division. World population prospects 2019: highlights. United Nations Department of Economic and Social Affairs | Multimedia Library; 2019 Jun 17 [accessed 2022 Mar 10]. https://www.un.org/development/desa/publications/world-population-prospects-2019-highlights.html.
  • Peck M, Gacic-Dobo M, Diallo M, Nedelec Y, Sodha S, Wallace A. Global routine vaccination coverage, 2018. MMWR Morb Mortal Wkly Rep. 2019;68(42):937–8. doi:10.15585/mmwr.mm6842a1.
  • Patel M, Dumolard L, Nedelec Y, Sodha S, Steulet C, Gacic-Dobo M, Kretsinger K, McFarland J, Rota P, Goodson J. Progress toward regional measles elimination — worldwide, 2000–2018. Morb Mortal Wkly Rep. 2019;68(48):1105–11. doi:10.15585/mmwr.mm6848a1.
  • European Centers for Disease Control and Prevention (ECDC). Vaccine scheduler | vaccine schedules in all countries in the EU/EEA. Vaccine scheduler; 2022 [accessed 2022 Mar 25]. https://vaccine-schedule.ecdc.europa.eu.
  • Wu L, Kanitz E, Crumly J, D’Ancona F, Strikas R. Adult immunization policies in advanced economies: vaccination recommendations, financing, and vaccination coverage. Int J Public Health. 2013;58(6):865–74. doi:10.1007/s00038-012-0438-x.
  • Privor-Dumm L, Vasudevan P, Kobayashi K, Gupta J. Archetype analysis of older adult immunization decision-making and implementation in 34 countries. Vaccine. 2020;38(26):4170–82. doi:10.1016/j.vaccine.2020.04.027.
  • Sauer M, Vasudevan P, Meghani A, Luthra K, Garcia C, Knoll M, Privor-Dumm L. Situational assessment of adult vaccine preventable disease and the potential for immunization advocacy and policy in low- and middle-income countries. Vaccine. 2021;39(11):1556–64. doi:10.1016/j.vaccine.2021.01.066.
  • Shapiro G, Gottfredson N, Leask J, Wiley K, Ganter-Restrepo F, Jones S, Menning L, Brewer N. COVID-19 and missed or delayed vaccination in 26 middle- and high-income countries: an observational survey. Vaccine. 2022;40(6):945–52. doi:10.1016/j.vaccine.2021.12.041.
  • Thomas R, Lorenzetti D. Interventions to increase influenza vaccination rates of those 60 years and older in the community. Cochrane Database Syst Rev. 2018;5. doi:10.1002/14651858.CD005188.pub4.
  • Tricco A, Lillie E, Zarin W, O’Brien K, Colquhoun H, Levac D, Moher D, Peters M, Horsley T, Weeks L, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467–73. doi:10.7326/M18-0850.
  • Popay J, Roberts H, Sowden A, Petticrew M, Arai L, Rodgers M, Britten N, Roen K, Duffy S. Guidance on the conduct of narrative synthesis in systematic reviews: a product from the ESRC methods programme. Lanc Univ. 2016;92. doi:10.13140/2.1.1018.4643.
  • Naito T, Suzuki M, Fujibayashi K, Kanazawa A, Takahashi H, Yokokawa H, Watanabe A. The estimated impact of the 5-year national vaccination program on the trend of 23-valent pneumococcal polysaccharide vaccine vaccination rates in the elderly in Japan, 2009–2018. J Infect Chemother. 2020;26(4):407–10. doi:10.1016/j.jiac.2019.12.011.
  • Yang J, Atkins K, Feng L, Pang M, Zheng Y, Liu X, Cowling B, Yu H. Seasonal influenza vaccination in China: landscape of diverse regional reimbursement policy, and budget impact analysis. Vaccine. 2016;34(47):5724–35. doi:10.1016/j.vaccine.2016.10.013.
  • Litt J, Booy R, Bourke D, Dwyer D, Leeb A, McCloud P, Stein A, Woodward M, Cunningham A. Early impact of the Australian national shingles vaccination program with the herpes zoster live attenuated vaccine. Hum Vaccines Immunother. 2020;16(12):3081–89. doi:10.1080/21645515.2020.1754702.
  • Brilli Y, Lucifora C, Russo A, Tonello M. Vaccination take-up and health: evidence from a flu vaccination program for the elderly. J Econ Behav Organ. 2020;179:323–34. doi:10.1016/j.jebo.2020.09.010.
  • Jiang X, Shang X, Lin J, Zhao Y, Wang W, Qiu Y. Impacts of free vaccination policy and associated factors on influenza vaccination behavior of the elderly in China: a quasi-experimental study. Vaccine. 2021;39(5):846–52. doi:10.1016/j.vaccine.2020.12.040.
  • Blank P, Essen G, Lejarazu R, Nitsch-Osuch A, Kuchar E, Falup-Percurariu O, Maltezou H, Zavadska D, Kristufkova Z, Kassianos G. Impact of European vaccination policies on seasonal influenza vaccination coverage rates: an update seven years later. Hum Vaccines Immunother. 2018 Aug;14(11):2706–14. doi:10.1080/21645515.2018.1489948.
  • Yan S, DerSarkissian M, Bhak R, Lefebvre P, Duh M, Krishnarajah G. Relationship between patient copayments in medicare part D and vaccination claim status for herpes zoster and tetanus-diphtheria-acellular pertussis. Curr Med Res Opin. 2018;34(7):1261–69. doi:10.1080/03007995.2017.1416347.
  • Hechter R, Qian L, Yan S, Luo Y, Krishnarajah G, Tseng H. Impact of the change of copay policy in medicare part D on zoster vaccine uptake among medicare beneficiaries in a managed care organization. BMC Health Serv Res. 2017 Jul;17(1):503. doi:10.1186/s12913-017-2441-7.
  • Yue M, Wang Y, Low C, Yoong J, Cook A. Optimal design of population-level financial incentives of influenza vaccination for the elderly. Value Health. 2020;23(2):200–08. doi:10.1016/j.jval.2019.08.006.
  • Herrett E, Williamson E, Staa T, Ranopa M, Free C, Chadborn T, Goldacre B, Smeeth L. Text messaging reminders for influenza vaccine in primary care: a cluster randomised controlled trial (TXT4FLUJAB). BMJ Open. 2016;6(2):e010069. doi:10.1136/bmjopen-2015-010069.
  • Szilagyi P, Albertin C, Casillas A, Valderrama R, Duru O, Ong M, Vangala S, Tseng C-H, Rand C, Humiston S, et al. Effect of patient portal reminders sent by a health care system on influenza vaccination rates. JAMA Intern Med. 2020;180(7):962–70. doi:10.1001/jamainternmed.2020.1602.
  • Sheer R, Nau D, Dorich N, Boyer A, Pickering M, Campbell P, Pasquale M. Medicare advantage-pharmacy partnership improves influenza and pneumococcal vaccination rates. Am J Manag Care. 2021;27(10):425–31. doi:10.37765/ajmc.2021.88760.
  • Burka A, Fann J, Lamb K, Salvig B, Smith T, Wallace J. Evaluation of a novel discharge reminder tool on pneumococcal vaccination in hospitalized elderly veterans. JACCP J Am Coll Clin Pharm. 2019;2(5):462–67. doi:10.1002/jac5.1078.
  • Erlandson K, Streifel A, Novin A, Hawkins K, Foster C, Langness J, Bessesen M, Falutz J, Moanna A, Looney D, et al. Low rates of vaccination for herpes zoster in older people living with HIV. AIDS Res Hum Retroviruses. 2018;34(7):603–06. doi:10.1089/aid.2017.0315.
  • McGreevy S, McGowan C, Gillenwater K, Opole R, Veluri M, Stehle K, Ramm B, Gibson C. Improving population health in resident clinics: increasing pneumonia vaccination rates in adults 65 years and older. BMJ Open Qual. 2020;9(4):e000830. doi:10.1136/bmjoq-2019-000830.
  • McAdam-Marx C, Tak C, Petigara T, Jones N, Yoo M, Briley M, Gunning K, Gren L Impact of a guideline-based best practice alert on pneumococcal vaccination rates in adults in a primary care setting. BMC Health Serv Res. 2019; 19: 1; 474. doi: 10.1186/s12913-019-4263-2.
  • Chen W, Stoecker C. Mass media coverage and influenza vaccine uptake. Vaccine. 2020;38(2):271–77. doi:10.1016/j.vaccine.2019.10.019.
  • Rosselli R, Martini M, Fluad Effect Working Group, Bragazzi N, Watad A. The public health impact of the so-called ‘fluad effect’ on the 2014/2015 influenza vaccination campaign in Italy: ethical implications for health-care workers and health communication practitioners. Adv Exp Med Biol. 2017;973:125–34. doi:10.1007/5584_2017_39.
  • Yokum D, Lauffenburger J, Ghazinouri R, Choudhry N. Letters designed with behavioural science increase influenza vaccination in medicare beneficiaries. Nat Hum Behav. 2018;2(10):10. doi:10.1038/s41562-018-0432-2.
  • Berkhout C, Willefert-Bouche A, Chazard E, Zgorska-Maynard-Moussa S, Favre J, Peremans L, Ficheur G, Royen P. Randomized controlled trial on promoting influenza vaccination in general practice waiting rooms. PLoS ONE. 2018;13(2):e0192155. doi:10.1371/journal.pone.0192155.
  • Leung K, Mui C, Chiu W, Ng Y, Chen M, Ho P, Kwok C, Lam S, Wong C, Wong K, et al. Impact of patient education on influenza vaccine uptake among community-dwelling elderly: a randomized controlled trial. Health Educ Res. 2017;32(5):455–64. doi:10.1093/her/cyx053.
  • Tao L, Lu M, Wang X, Han X, Li S, Wang H. The influence of a community intervention on influenza vaccination knowledge and behavior among diabetic patients. BMC Public Health. 2019;19:1747. doi:10.1186/s12889-019-8101-6.
  • Abu-Rish E, Barakat N. The impact of pharmacist-led educational intervention on pneumococcal vaccine awareness and acceptance among elderly in Jordan. Hum Vaccines Immunother. 2020;17(4):1181–89. doi:10.1080/21645515.2020.1802973.
  • Schattner A. Cardiovascular-targeted patient education and uptake of influenza vaccination in elderly patients. Patient Educ Couns. 2020;103(5):1052–54. doi:10.1016/j.pec.2019.12.008.
  • Pizzi L, Prioli K, Harris L, Cannon-Dang E, Marthol-Clark M, Alcusky M, McCoy M, Schafer J. Knowledge, activation, and costs of the Pharmacists’ Pneumonia Prevention Program (PPPP): a novel senior center model to promote vaccination. Ann Pharmacother. 2018;52(5):446–53. doi:10.1177/1060028017745566.
  • Biyik M, Arslan I, Taci D. Study to increase the pneumococcal vaccination rates of individuals aged 65 years and older. Prim Health Care Res Dev. 2020;21:e37. doi:10.1017/S1463423620000389.
  • Yuruyen M, Ayan G, Demirdağ F, Kara Z, Avcı S, Yavuzer H, Doventas A, Erdinçler D. Why is vaccination frequency low in elderly patients? Ann Clin Anal Med. 2018;9:2. doi:10.4328/JCAM.5611.
  • Higuchi M, Narumoto K, Goto T, Inoue M. Correlation between family physician’s direct advice and pneumococcal vaccination intention and behavior among the elderly in Japan: a cross-sectional study. BMC Fam Pract. 2018;19(1):153. doi:10.1186/s12875-018-0841-3.
  • Lv M, Fang R, Wu J, Pang X, Deng Y, Lei T, Xie Z. The free vaccination policy of influenza in Beijing, China: the vaccine coverage and its associated factors. Vaccine. 2016;34(18):2135–40. doi:10.1016/j.vaccine.2016.02.032.
  • Yi B, Zhou S, Song Y, Chen F, Xuyin L, Cai J, Greene C, Feng L, Zheng J, Dong H, et al. Innovations in adult influenza vaccination in China, 2014–2015: leveraging a chronic disease management system in a community-based intervention. Hum Vaccines Immunother. 2018;14(4):947–51. doi:10.1080/21645515.2017.1403704.
  • Wright W, Bruns D, Feeney A, Strowman S. Improving vaccination rates in older adults: a quality improvement project. Nurse Pract. 2019;44(4):40–49. doi:10.1097/01.NPR.0000554085.13073.37.
  • Healy A, Svendsen M, Reynolds A, Heisler J, Huntington M. Enhancing immunization rates for senior citizens in South Dakota family medicine residency practices. S D Med J S D State Med Assoc. 2019;72(4):164–67. PMID: 31436929.
  • Nowalk M, Nolan B, Nutini J, Ahmed F, Albert S, Susick M, Zimmerman R. Success of the 4 pillars toolkit for influenza and pneumococcal vaccination in adults. J Healthc Qual off Publ Natl Assoc Healthc Qual. 2014;36(6):5–15. doi:10.1111/jhq.12020.
  • Nowalk M, Moehling K, Zhang S, Raviotta J, Zimmerman R, Lin C. Using the 4 pillarsTM to increase vaccination among high-risk adults: who benefits? Am J Manag Care. 2017;23(11):651–55. doi:10.1186/s12879-016-1940-1.
  • Zimmerman R, Brown A, Pavlik V, Moehling K, Raviotta J, Lin C, Zhang S, Hawk M, Kyle S, Patel S, et al. Using the 4 pIllars practice transformation program to increase pneumococcal immunizations for older adults: a cluster-randomized trial. J Am Geriatr Soc. 2017;65(1):114–22. doi:10.1111/jgs.14451.
  • Itamochi T, Mieno M, Hatakeyama S. Influenza vaccination coverage in Chiburijima Island, Japan: impact of diversification of vaccination place. J Gen Fam Med. 2020;21(5):178–84. doi:10.1002/jgf2.335.
  • Restivo V, Orsi A, Ciampini S, Messano G, Trucchi C, Ventura G, Casuccio A, Vitale F, the Leadership in Public Health Group. How should vaccination services be planned, organized, and managed? Results from a survey on the Italian vaccination services. Ann Ig Med Prev E Comunita. 2019;31(2):45–53. doi:10.7416/ai.2019.2276.
  • Ko H, Kim M. Impacts of expanding provider choice for free flu vaccination among the elderly in Korea. Health Policy (New York). 2020;24(10):1115–20. doi:10.1016/j.healthpol.2020.07.014.
  • Isenor J, Killen J, Billard B, McNeil S, MacDougall D, Halperin B, Slayter K, Bowles S. Impact of pharmacists as immunizers on influenza vaccination coverage in the community-setting in Nova Scotia, Canada: 2013-2015. J Pharm Policy Pract. 2016;9(1):32. doi:10.1186/s40545-016-0084-4.
  • Buchan S, Rosella L, Finkelstein M, Juurlink D, Isenor J, Marra F, Patel A, Russell M, Quach S, Waite N, et al. Impact of pharmacist administration of influenza vaccines on uptake in Canada. CMAJ Can Med Assoc J. 2017;189(4):E146–52. doi:10.1503/cmaj.151027.
  • Blanchi S, Vaux J, Toqué J, Héry L, Laforest S, Piccoli G, Crochette N. Impact of a catch-up strategy of DT-IPV vaccination during hospitalization on vaccination coverage among people over 65 years of age in France: the HOSPIVAC study (vaccination during hospitalization). Vaccines. 2020;8(2):292. doi:10.3390/vaccines8020292.
  • Vann J, Jacobson R, Coyne-Beasley T, Asafu-Adjei J, Szilagyi P. Patient reminder and recall interventions to improve immunization rates. Cochrane Database Syst Rev. 2018;1(1). CD003941. doi:10.1002/14651858.CD003941.pub3.
  • Bae J, Ford E, Wu S, Huerta T. Electronic reminder’s role in promoting human papillomavirus vaccine use. Am J Manag Care. 2017;23(11):e353–59. PMID: 29182355.
  • Murray E, Bieniek K, Aguila M, Egodage S, Litzinger S, Mazouz A, Mills H, Liska J. Impact of pharmacy intervention on influenza vaccination acceptance: a systematic literature review and meta-analysis. Int J Clin Pharm. 2021;43(5):1163–72. doi:10.1007/s11096-021-01250-1.
  • Community Preventative Services Task Force (CPSTF). Increasing appropriate vaccination: community-based interventions implemented in combination. Community Guide; 2015 Feb. https://www.thecommunityguide.org/sites/default/files/assets/Vaccination-Community-Based-in-Combination.pdf.
  • Community Preventative Services Task Force (CPSTF). Vaccination programs: community-based interventions implemented in combination. Community Guide; 2014 Oct. https://www.thecommunityguide.org/findings/vaccination-programs-community-based-interventions-implemented-combination.